Author

Samar H. Abbas

Observed names: Abbas, Samar H, Abbas, Samar H., Samar ABBAS, Samar Abbas, Samar Hafez Abbas

Institution: Minia University

Observed institution: Minia University

ORCID: 0000-0002-9586-2644

Observed ORCID: 0000-0002-9586-2644

OpenAlex ID: A5033562597

Recent updates of fluoroquinolones as antibacterial agents

2018 · Hend A. A. Ezelarab, Samar H. Abbas, et al. · Archiv der Pharmazie · 177

New 1,2,4-triazole-Chalcone hybrids induce Caspase-3 dependent apoptosis in A549 human lung adenocarcinoma cells

2018 · Fatma F. Ahmed, Amer Ali Abd El-Hafeez, et al. · European Journal of Medicinal Chemistry · 90

1,3,4-oxadiazole/chalcone hybrids: Design, synthesis, and inhibition of leukemia cell growth and EGFR, Src, IL-6 and STAT3 activities

2018 · Marwa Ali A. Fathi, Amer Ali Abd El-Hafeez, et al. · Bioorganic Chemistry · 79

New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity

2018 · Samar H. Abbas, Amer Ali Abd El-Hafeez, et al. · Bioorganic Chemistry · 72

New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization

2022 · Hamada H. H. Mohammed, Amer Ali Abd El-Hafeez, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 69

PDF

Insights into fourth generation selective inhibitors of (C797S) EGFR mutation combating non-small cell lung cancer resistance: a critical review

2023 · Mostafa A. Mansour, Asmaa M. AboulMagd, et al. · RSC Advances · 67

PDF

Current Trends and Future Directions of Fluoroquinolones

2018 · Hamada H.H. Mohammed, Gamal El-Din A.A. Abuo-Rahma, et al. · Current Medicinal Chemistry · 63

New antiproliferative 7-(4-(N-substituted carbamoylmethyl)piperazin-1-yl) derivatives of ciprofloxacin induce cell cycle arrest at G2/M phase

2016 · Hamada H.H. Mohammed, Amer Ali Abd El-Hafeez, et al. · Bioorganic & Medicinal Chemistry · 43

Chalcone/1,3,4-Oxadiazole/Benzimidazole hybrids as novel anti-proliferative agents inducing apoptosis and inhibiting EGFR & BRAFV600E

2023 · Fatma Fouad Hagar, Samar H. Abbas, et al. · BMC Chemistry · 38

PDF

Benzimidazole scaffold as a potent anticancer agent with different mechanisms of action (2016–2023)

2024 · Fatma Fouad Hagar, Samar H. Abbas, et al. · Molecular Diversity · 37

Synthesis, cytotoxic activity, and tubulin polymerization inhibitory activity of new pyrrol-2(3H)-ones and pyridazin-3(2H)-ones

2016 · Samar Hafez Abbas, Gamal El-Din A.A. Abuo-Rahma, et al. · Bioorganic Chemistry · 35

Novel urea linked ciprofloxacin-chalcone hybrids having antiproliferative topoisomerases I/II inhibitory activities and caspases-mediated apoptosis

2020 · Hamada H.H. Mohammed, Samar H. Abbas, et al. · Bioorganic Chemistry · 32

Design, synthesis and molecular docking of new N-4-piperazinyl ciprofloxacin-triazole hybrids with potential antimicrobial activity

2019 · Hamada H.H. Mohammed, El-Shimaa M.N. Abdelhafez, et al. · Bioorganic Chemistry · 31

New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization

2023 · Hend A. A. Ezelarab, Taha F. S. Ali, et al. · Molecular Diversity · 28

PDF

New 1,3,4‐oxadiazole‐chalcone/benzimidazole hybrids as potent antiproliferative agents

2022 · Fatma Fouad Hagar, Samar H. Abbas, et al. · Archiv der Pharmazie · 26

Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors

2022 · Hamada H. H. Mohammed, Doaa Mohamed Elroby Ali, et al. · Molecular Diversity · 23

PDF

Design, synthesis, and biological investigation of quinoline/ciprofloxacin hybrids as antimicrobial and anti-proliferative agents

2022 · Hend A. A. Ezelarab, Heba A. Hassan, et al. · Journal of the Iranian Chemical Society · 21

PDF

Synthesis and antimicrobial evaluation of new nitric oxide‐donating fluoroquinolone/oxime hybrids

2020 · Hossameldin A. Aziz, Gamal A. I. Moustafa, et al. · Archiv der Pharmazie · 21

PDF

Indole-based FLT3 inhibitors and related scaffolds as potential therapeutic agents for acute myeloid leukemia

2023 · Hend A. A. Ezelarab, Taha F. S. Ali, et al. · BMC Chemistry · 18

PDF

Synthesis, molecular docking, antimicrobial evaluation, and DNA cleavage assay of new thiadiazole/oxadiazole ciprofloxacin derivatives

2019 · Hamada H. H. Mohammed, Samar H. Abbas, et al. · Monatshefte für Chemie - Chemical Monthly · 18

Quinazoline‐chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in‐silico studies of potential anticancer activity against multiple myeloma

2024 · Mostafa A. Mansour, Asmaa M. AboulMagd, et al. · Archiv der Pharmazie · 16

New fluoroquinolones/nitric oxide donor hybrids: design, synthesis and antitubercular activity

2019 · Hossameldin A. Aziz, Gamal A. I. Moustafa, et al. · Medicinal Chemistry Research · 15

New antiproliferative 1,3,4-oxadiazole/benzimidazole derivatives: Design, synthesis, and biological evaluation as dual EGFR and BRAFV600E inhibitors

2025 · Fatma Fouad Hagar, Samar H. Abbas, et al. · Bioorganic Chemistry · 14

Novel antimicrobial ciprofloxacin-pyridinium quaternary ammonium salts with improved physicochemical properties and DNA gyrase inhibitory activity

2021 · Hend A. A. Ezelarab, Samar H. Abbas, et al. · Medicinal Chemistry Research · 13

New norfloxacin/nitric oxide donor hybrids: Synthesis and nitric oxide release measurement using a modified Griess colorimetric method

2017 · Hossameldin Ali Aziz, Gamal Abdeltawab Idris Moustafa, et al. · European Journal of Chemistry · 13

Works count: 50

Citation count: 1,121

H-index: 18

I10-index: 26